Chaojia Chen

机构：Jackson Laboratory · ORCID：0000-0001-8191-8224

发表论文 19 篇 · 总被引 311 次 · h-index 8

代表论文

• Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8+ T cell exhaustion and anti-PD-1 resistance (2024 · Cell Reports Medicine · 被引 58)
• Identification of a small-molecule Tim-3 inhibitor to potentiate T cell–mediated antitumor immunotherapy in preclinical mouse models (2023 · Science Translational Medicine · 被引 55)
• LINC01431 Promotes Histone H4R3 Methylation to Impede HBV Covalently Closed Circular DNA Transcription by Stabilizing PRMT1 (2022 · Advanced Science · 被引 44)
• ZHX2 inhibits SREBP1c ‐mediated de novo lipogenesis in hepatocellular carcinoma via miR ‐24‐3p (2020 · The Journal of Pathology · 被引 40)
• Ribosomal protein S26 serves as a checkpoint of T-cell survival and homeostasis in a p53-dependent manner (2021 · Cellular and Molecular Immunology · 被引 32)
• Urolithin A Hijacks ERK1/2‐ULK1 Cascade to Improve CD8 + T Cell Fitness for Antitumor Immunity (2024 · Advanced Science · 被引 30)